From: Concomitant Guillain-Barre syndrome with COVID-19: a case report
Laboratory testing upon admission | ||
---|---|---|
Complete blood count | Reference range | |
Total leucocyte count | 12.57 (103/mm3) | 4–10.04 (103/mm3) |
Neutrophils | 79.9% | 34–71.1% |
Lymphocytes | 13% | 19.3–51.7% |
Monocytes | 6.6% | 4.7–12.6% |
Eosinophils | 0.4% | 0.7–5.8% |
Basophils | 0.1% | 0.1–1.2% |
Haematocrit | 35.6% | 34.1–44.9% |
Haemoglobin | 11.2 g/dL | 11.2–15.7 (gr/dL) |
Platelets | 232 (103 uL) | 150–450 (103 uL) |
Electrolytes | ||
Sodium | 136 mmol/L | 135–148 mmol/L |
Potassium | 4.57 mmol/L | 3.3–5.1 mmol/L |
Chloride | 96.5 mmol/L | 98–107 mmol/L |
Blood glucose levels | ||
Glycemia | 240 (mg/dL) | 70–105 (mg/dL) |
Others | ||
Lactate dehydrogenase | 306 (U/L) | 140–280 U/L |
Ferritin | 114.5 ng/mL | 15–150 ng/mL |
D-dimer | 517 ng/mL | < 250 ng/mL |
Serum creatinine | 0.51 mg/dL | 0.5–1.1 mg/dL |
Erythrocyte sedimentation rate (ESR) | 65 | 0–25 mm/hour |